Methodological improvements to meta-analysis of low dose rate studies and derivation of dose and dose-rate effectiveness factors
- 4 July 2021
- journal article
- research article
- Published by Springer Nature in Radiation and Environmental Biophysics
- Vol. 60 (3) , 485-491
Abstract
Epidemiological studies of cancer rates associated with external and internal exposure to ionizing radiation have been subject to extensive reviews by various scientific bodies. It has long been assumed that radiation-induced cancer risks at low doses or low-dose rates are lower (per unit dose) than those at higher doses and dose rates. Based on a mixture of experimental and epidemiologic evidence the International Commission on Radiological Protection recommended the use of a dose and dose-rate effectiveness factor for purposes of radiological protection to reduce solid cancer risks obtained from moderate-to-high acute dose studies (e.g. those derived from the Japanese atomic bomb survivors) when applied to low dose or low-dose rate exposures. In the last few years there have been a number of attempts at assessing the effect of extrapolation of dose rate via direct comparison of observed risks in low-dose rate occupational studies and appropriately age/sex-adjusted analyses of the Japanese atomic bomb survivors. The usual approach is to consider the ratio of the excess relative risks in the two studies, a measure of the inverse of the dose rate effectiveness factor. This can be estimated using standard meta-analysis with inverse weighting of ratios of relative risks using variances derived via the delta method. In this paper certain potential statistical problems in the ratio of estimated excess relative risks for low-dose rate studies to the excess relative risk in the Japanese atomic bomb survivors are discussed, specifically the absence of a well-defined mean and the theoretically unbounded variance of this ratio. A slightly different method of meta-analysis for estimating uncertainties of these ratios is proposed, motivated by Fieller’s theorem, which leads to slightly different central estimates and confidence intervals for the dose rate effectiveness factor. However, given the uncertainties in the data, the differences in mean values and uncertainties from the dose rate effectiveness factor estimated using delta-method-based meta-analysis are not substantial, generally less than 70%.Keywords
Funding Information
- Division of Cancer Epidemiology and Genetics (Intramural program)
This publication has 26 references indexed in Scilit:
- Shared Dosimetry Error in Epidemiological Dose-Response AnalysesPLOS ONE, 2015
- Modelling complex mixtures in epidemiologic analysis: additive versus relative measures for differential effectivenessOccupational and Environmental Medicine, 2013
- Is cancer risk of radiation workers larger than expected?Occupational and Environmental Medicine, 2009
- Solid Cancer Incidence in Atomic Bomb Survivors: 1958–1998Radiation Research, 2007
- Preface, Executive Summary and GlossaryAnnals of the ICRP, 2007
- Bias and Efficiency of Meta-Analytic Variance Estimators in the Random-Effects ModelJournal of Educational and Behavioral Statistics, 2005
- Exposure Measurement Error: Influence on Exposure-Disease Relationships and Methods of CorrectionAnnual Review of Public Health, 1993
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- Confidence Set for the Ratio of Means of Two Normal Distributions when the Ratio of Variances is unknownBiometrische Zeitschrift, 1971
- The Biological Standardization of InsulinJournal of the Royal Statistical Society Series B: Statistical Methodology, 1941